SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Strategic Formulary Design in Medicare Part D Plans
16 references·2 citing·47 second hop
Strategic Formulary Design in Medicare Part D Plans (2018)Strategic Formulary Design in Medicare Pa…Upcoding: Evidence from Medicare on Squishy Risk Adjustment (2019)Upcoding: Evidence from Medic…Screening in Contract Design: Evidence from the ACA Health Insurance Exchanges (2019)Screening in Contract Design:…Private Provision of Social Insurance: Drug-Specific Price Elasticities and Cost Sharing in Medicare Part D (2018)Private Provision of Social I…Do Larger Health Insurance Subsidies Benefit Patients or Producers? Evidence from Medicare Advantage (2018)Do Larger Health Insurance Su…Choice Inconsistencies among the Elderly: Evidence from Plan Choice in the Medicare Part D Program: Reply (2016)Choice Inconsistencies among …Medicare Part D: Are Insurers Gaming the Low Income Subsidy Design? (2015)Medicare Part D: Are Insurers…How Does Risk Selection Respond to Risk Adjustment? New Evidence from the Medicare Advantage Program (2014)How Does Risk Selection Respo…Adverse Selection and Inertia in Health Insurance Markets: When Nudging Hurts (2013)Adverse Selection and Inertia…Sinking, Swimming, or Learning to Swim in Medicare Part D (2012)Sinking, Swimming, or Learnin…The Effect of Medicare Part D on Pharmaceutical Prices and Utilization (2010)The Effect of Medicare Part D…Patient Cost-Sharing and Hospitalization Offsets in the Elderly (2010)Patient Cost-Sharing and Hosp…The Impact Of Medicare Part D On Prescription Drug Use By The Elderly (2007)The Impact Of Medicare Part D…Adverse Events Associated With Prescription Drug Cost-Sharing Among Poor and Elderly Persons (2001)Adverse Events Associated Wit…A benefit-based copay for prescription drugs: patient contribution based on total benefits, not drug acquisition cost. (2001)A benefit-based copay for pre…The Medicare-HMO Revolving Door — The Healthy Go in and the Sick Go Out (1997)The Medicare-HMO Revolving Do…Equilibrium in Competitive Insurance Markets: An Essay on the Economics of Imperfect Information (1976)Equilibrium in Competitive In…The Effect of State Medicaid Expansions on Prescription Drug Use: Evidence from the Affordable Care Act (2017)The Effect of State Medicaid …Measuring efficiency of health plan payment systems in managed competition health insurance markets (2017)Measuring efficiency of healt…Health insurance and the demand for medical care: evidence from a randomized experiment. (1987)Free for All? Lessons from the RAND Health Insurance Experiment (1995)A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study (2013)Best care at lower cost: the path to continuously learning health care in America (2014)Behavioral Hazard in Health Insurance * (2015)The Quarterly Journal of Economics (2024)Health Care Financing Review (1980)Multitask Principal–Agent Analyses: Incentive Contracts, Asset Ownership, and Job Design (1991)The Proper Scope of Government: Theory and an Application to Prisons (1997)Pricing and Welfare in Health Plan Choice (2012)Consumer Inertia and Firm Pricing in the Medicare Part D Prescription Drug Insurance Exchange (2014)The Market for "Lemons": Quality Uncertainty and the Market Mechanism (1970)Risk Aversion and Incentive Effects (2002)Nudge: improving decisions about health, wealth, and happiness (2008)Behavioral Economics and Public Policy: A Pragmatic Perspective (2015)Health Insurance for “Humans”: Information Frictions, Plan Choice, and Consumer Welfare (2015)What does a Deductible Do? The Impact of Cost-Sharing on Health Care Prices, Quantities, and Spending Dynamics* (2017)Geographic Variation in Expenditures for Physicians' Services in the United States (1993)Effects of Race and Income on Mortality and Use of Services among Medicare Beneficiaries (1996)Quality of Care in Investor-Owned vs Not-for-Profit HMOs (1999)Effects of health insurance and race on colorectal cancer treatments and outcomes (2000)Out-of-pocket health care costs among older Americans (2000)Does Public Insurance Crowd out Private Insurance? (1996)The Effect of the Medicare Part D Prescription Benefit on Drug Utilization and Expenditures (2008)Economics of the Pharmaceutical Industry (2018)Essays in the Theory of Risk-Bearing. (1972)Higher education as a filter (1973)Job Market Signaling (1973)INFORMATIONAL ASYMMETRIES, FINANCIAL STRUCTURE, AND FINANCIAL INTERMEDIATION (1977)Signaling Games and Stable Equilibria (1987)Understanding and Mitigating Uncertainty in Online Exchange Relationships: A Principal–Agent Perspective1 (2007)The Aggregate Effects of Health Insurance: Evidence from the Introduction of Medicare (2007)The Impact of Nearly Universal Insurance Coverage on Health Care Utilization: Evidence from Medicare (2008)Are Health Insurance Markets Competitive? (2010)The Response of Drug Expenditure to Nonlinear Contract Design: Evidence from Medicare Part D * (2015)The Costs and Benefits of Ownership: A Theory of Vertical and Lateral Integration (1986)Truth-telling by Third-party Auditors and the Response of Polluting Firms: Experimental Evidence from India* (2013)Ethical Machine Learning in Healthcare (2021)Place-Based Drivers of Mortality: Evidence from Migration (2021)Association of Private Equity Acquisition of Physician Practices With Changes in Health Care Spending and Utilization (2022)The Age of Reason: Financial Decisions over the Life Cycle and Implications for Regulation (2009)Choice proliferation, simplicity seeking, and asset allocation (2010)Comparison Friction: Experimental Evidence from Medicare Drug Plans (2012)The Industrial Organization of Health-Care Markets (2015)Pharmacy Benefits and the Use of Drugs by the Chronically Ill (2004)Prescription drug cost sharing: associations with medication and medical utilization and spending and health. (2007)Medical Bankruptcy in the United States, 2007: Results of a National Study (2009)
this work references cited by second hop

References

  • 1976Equilibrium in Competitive Insurance Markets: An Essay on the Economics of Imperfect Information5,032 cited
  • 2001Adverse Events Associated With Prescription Drug Cost-Sharing Among Poor and Elderly Persons873 cited
  • 2013Adverse Selection and Inertia in Health Insurance Markets: When Nudging Hurts705 cited
  • 2016Choice Inconsistencies among the Elderly: Evidence from Plan Choice in the Medicare Part D Program: Reply539 cited
  • 2010Patient Cost-Sharing and Hospitalization Offsets in the Elderly408 cited
  • 2014How Does Risk Selection Respond to Risk Adjustment? New Evidence from the Medicare Advantage Program265 cited
  • 2019Upcoding: Evidence from Medicare on Squishy Risk Adjustment251 cited
  • 1997The Medicare-HMO Revolving Door — The Healthy Go in and the Sick Go Out229 cited
  • 2007The Impact Of Medicare Part D On Prescription Drug Use By The Elderly223 cited
  • 2010The Effect of Medicare Part D on Pharmaceutical Prices and Utilization211 cited
  • 2001A benefit-based copay for prescription drugs: patient contribution based on total benefits, not drug acquisition cost.184 cited
  • 2012Sinking, Swimming, or Learning to Swim in Medicare Part D182 cited
  • 2018Do Larger Health Insurance Subsidies Benefit Patients or Producers? Evidence from Medicare Advantage128 cited
  • 2019Screening in Contract Design: Evidence from the ACA Health Insurance Exchanges

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

89 cited
  • 2018Private Provision of Social Insurance: Drug-Specific Price Elasticities and Cost Sharing in Medicare Part D87 cited
  • 2015Medicare Part D: Are Insurers Gaming the Low Income Subsidy Design?86 cited
  • Cited by

    • 2017Measuring efficiency of health plan payment systems in managed competition health insurance markets56 cited
    • 2017The Effect of State Medicaid Expansions on Prescription Drug Use: Evidence from the Affordable Care Act53 cited